StockData
Assembly Biosciences, Inc. logo

Assembly Biosciences, Inc. (ASMB) stock

ASMBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 12/309% below fair value
$22.50+1.21 (+5.68%)

Close on Nov 17, 2026Market cap $458.11MP/E –Yield –

Assembly Biosciences operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Assembly Biosciences's operating cash flow for the twelve months ending Jun 30, 2026 was -$38.48M. For fiscal 2025 it was -$41.09M. The highest annual figure on record is $22.74M in fiscal 2023.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$41.09M–
FY2024Dec 31, 2024-$51.12M-324.8%
FY2023Dec 31, 2023$22.74M–
FY2022Dec 31, 2022-$84.46M–
FY2021Dec 31, 2021-$93.40M–
FY2020Dec 31, 2020-$62.96M–
FY2019Dec 31, 2019-$84.07M–
FY2018Dec 31, 2018-$64.96M-3592.4%
FY2017Dec 31, 2017$1.86M–
FY2016Dec 31, 2016-$34.88M–
FY2015Dec 31, 2015-$18.70M–
FY2014Dec 31, 2014-$14.97M–
FY2013Dec 31, 2013-$17.80M–
FY2012Dec 31, 2012-$21.38M–
FY2011Dec 31, 2011-$25.07M–
FY2010Dec 31, 2010-$5.21M–
FY2009Dec 31, 2009-$3.48M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$15.49M–
Q1 FY2026Mar 31, 2026-$22.10M–
Q4 FY2025Dec 31, 2025$14.24M–
Q3 FY2025Sep 30, 2025-$15.13M–
Q2 FY2025Jun 30, 2025-$16.76M–
Q1 FY2025Mar 31, 2025-$23.44M–
Q4 FY2024Dec 31, 2024-$407.00K-100.6%
Q3 FY2024Sep 30, 2024-$15.24M–
Q2 FY2024Jun 30, 2024-$17.10M–
Q1 FY2024Mar 31, 2024-$18.36M–
Q4 FY2023Dec 31, 2023$73.65M–
Q3 FY2023Sep 30, 2023-$13.85M–
Q2 FY2023Jun 30, 2023-$13.63M–
Q1 FY2023Mar 31, 2023-$23.43M–
Q4 FY2022Dec 31, 2022-$19.25M–
Q3 FY2022Sep 30, 2022-$19.82M–
Q2 FY2022Jun 30, 2022-$17.89M–
Q1 FY2022Mar 31, 2022-$27.50M–
Q4 FY2021Dec 31, 2021-$19.36M–
Q3 FY2021Sep 30, 2021-$18.88M-277.4%
Q2 FY2021Jun 30, 2021-$21.81M–
Q1 FY2021Mar 31, 2021-$33.34M–
Q4 FY2020Dec 31, 2020-$25.27M–
Q3 FY2020Sep 30, 2020$10.65M–
Q2 FY2020Jun 30, 2020-$23.12M–
Q1 FY2020Mar 31, 2020-$25.22M–
Q4 FY2019Dec 31, 2019-$20.53M–
Q3 FY2019Sep 30, 2019-$18.60M–
Q2 FY2019Jun 30, 2019-$21.01M–
Q1 FY2019Mar 31, 2019-$23.94M–
Q4 FY2018Dec 31, 2018-$16.73M–
Q3 FY2018Sep 30, 2018-$16.68M–
Q2 FY2018Jun 30, 2018-$16.05M–
Q1 FY2018Mar 31, 2018-$15.50M-144.4%
Q4 FY2017Dec 31, 2017-$9.77M–
Q3 FY2017Sep 30, 2017-$10.96M–
Q2 FY2017Jun 30, 2017-$12.36M–
Q1 FY2017Mar 31, 2017$34.94M–
Q4 FY2016Dec 31, 2016-$11.04M–
Q3 FY2016Sep 30, 2016-$7.86M–

More Assembly Biosciences figures

See a number that looks wrong?